2021 US Medicinal Products

Financial Strength Rankings using Artificial Intelligence

Top rated13 of 53
Best rating452 %
Worst rating-8,255 %
New companies7
Negative Economic Capital Ratio25 of 53

MARIMED INC. climbed 24 positions from 45 to 21 due it’s excellent Net Income. CAT9 Group Inc. lost 23 positions from 20 to 43 due it’s bad Assets. Canopy Growth Corp entered the 2021 ranking at rank 26, making it the best newcomer.

Revenues34.1 B
Assets65.7 B
Expenses35.7 B
Stockholders Equity30.1 B
Unprofitable companies39 of 53

2. NEOGEN CORP

235.34%

4. INNOSPEC INC.

171.02%

5. BALCHEM CORP

169.53%

7. FMC CORP

162.79%

10. Cronos Group Inc.

150.10%

11. Huntsman CORP

121.22%

12. HESKA CORP

110.92%

13. MANNATECH INC

108.53%

15. IMMUCELL CORP DE

103.11%

16. Livent Corp.

84.66%

18. CYANOTECH CORP

79.63%

19. Ingevity Corp

72.64%

20. BIOMERICA INC

60.38%

21. MARIMED INC.

53.77%

24. Chemours Co

27.94%

26. Canopy Growth Corp

15.40%

27. Ecovyst Inc.

9.29%

28. W R GRACE & CO

4.12%

29. OLIN Corp

-27.98%

30. Stem Holdings Inc.

-54.26%

33. Tilray Brands Inc.

-91.22%

36. Quotient Ltd

-184.92%

38. ChromaDex Corp.

-208.42%

39. Target Group Inc.

-224.08%

40. Hanjiao Group Inc.

-233.73%

42. NUTRA PHARMA CORP

-260.65%

43. CAT9 Group Inc.

-262.74%

44. VOLITIONRX LTD

-360.47%

50. QUANTA INC

-1761.52%

United States Ratings

German Insurance Ratings